Biotech and Pharmaceuticals
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that […]
Read More
UnitedHealth Group shares plunge 18% on reported DOJ probe into possible Medicare fraud
Bloomberg | Bloomberg | Getty Images Shares of UnitedHealth Group plunged more than 18% on Thursday following a report that the Justice Department is conducting a criminal investigation into the health-care giant over possible Medicare fraud. The DOJ is focusing on the company’s Medicare Advantage business practices, but the exact nature of the potential criminal […]
Read More
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. Spencer Platt | Getty Images News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]
Read More
UnitedHealth Group CEO Andrew Witty steps down, company suspends annual forecast
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America’s Health Care: Assessing the Change Healthcare Cyber Attack and What’s Next,” in the Dirksen Building in Washington, D.C., on May 1, 2024. Tom Williams | Cq-roll Call, Inc. | Getty Images UnitedHealth Group on Tuesday announced the surprise exit […]
Read More
Trump’s plan to slash drug prices may struggle to get off the ground – here’s what to know
President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S. […]
Read More
Trump to sign order to cut some U.S. drug prices to match lower ones abroad
President Donald Trump on Monday will revive a controversial policy that aims to slash drug costs by tying the amount the government pays for some medicines to lower prices abroad, White House officials said. Trump will sign an executive order including several different actions to renew that effort, known as the “most favored nation” policy. […]
Read More
Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround
A robotic arm fills prescriptions at a Walgreens’ micro-fulfillment center. Courtesy: Walgreens As struggling drugstore chains work to regain their footing, Walgreens is doubling down on automation. The company is expanding the number of retail stores served by its micro-fulfillment centers, which use robots to fill thousands of prescriptions for patients who take medications to […]
Read More
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won’t derail Eli Lilly’s obesity market dominance
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Despite […]
Read More
Novo Nordisk cuts 2025 guidance as drug copycats hit Wegovy sales, posts first-quarter profit beat
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk on Wednesday reported a better-than-expected rise in […]
Read More
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
US President Donald Trump speaks during a cabinet meeting in the Cabinet Room of the White House in Washington, DC, on April 30, 2025. Jim Watson | Afp | Getty Images President Donald Trump on Monday signed an executive order to incentivize drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build […]
Read More